Meili Tianyuan Medical Health Forecasts Higher Interim Profit And Revenue

Meili Tianyuan Medical Health (2373) said it expects interim net profit of no less than RMB 235 million, up at least 37% from the same period in 2025, with revenue of no less than RMB 1.88 billion, up at least 28%, according to Ming Pao. The company also forecast adjusted net profit of no less than RMB 260 million, representing growth of at least 36% from the same period in 2025.